(NASDAQ:NMRA), NMRA-861 has potential best-in-class pharmacology, which may enable a more favorable therapeutic profile No convulsions observed in pre-clinical studies conducted in multiple species, including rabbits WATERTOWN, Mass., July 09, 2025 (GLOBE NEWSWIRE) — Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of seven brain disease programs including three […]

ALEXANDRIA, Va., July 09, 2025 (GLOBE NEWSWIRE) — HRCI, the premier credentialing and learning community for the human resource profession, today announced its newest AI-powered resource, HRCI CHAT. Available on a complimentary basis to HRCI account holders, HRCI CHAT is a 24/7 virtual assistant able to transform everyday HR operations into strategic, high-impact work. According

PS-002, Purespring's lead precision nephrology programme, targets the complement pathway known to be a driver of IgA nephropathy IND clearance follows the granting of European Medicine Agency (EMA) orphan drug designation in April 2025 First patient expected to be enrolled in 2025 London – 9 July 2025 – Purespring Therapeutics, a precision nephrology company focused

Integration unlocks Galaxy's institutional staking platform for Fireblocks clients, enabling secure, capital-efficient on-chain participation at scale Galaxy Digital Inc. (NASDAQ: GLXY) (TSX: GLXY)announced today that it has integrated with Fireblocks, the leading digital asset and payments infrastructure platform for moving, storing, and issuing digital assets. This collaboration significantly broadens access to Galaxy's staking services by

ChemPoint LLC (“ChemPoint”), a subsidiary of Univar Solutions LLC, a leading global solutions provider to users of specialty ingredients and chemicals, today announced the launch ofChemPoint Ireland Ltd (“ChemPoint Ireland”). This strategic move marks the establishment of ChemPoint's new EMEA (Europe, Middle East, and Africa) headquarters in Dublin. https://mma.prnewswire.com/media/2727312/Austin_and_Anna.jpg ChemPoint Establishes EMEA Headquarters in Dublin,

Next-Gen Initiatives Anticipate Rapidly Evolving Developer Expectations, Impact of AI on Hiring Integrity and Skills Development At the forefront of a new era of software development where humans and AI build together,HackerRank, the Developer Skills Company, is ensuring that organizations can rapidly integrate AI into their enterprise. As companies rethink technical hiring and upskilling strategies,

Friday, August 1, 2025 the 5th Annual PILGRIM FAMILYFEST will get underway at PILGRIM FIELD in Buffalo NY. Gospel recording artist and songwriter REV. FRANK BOSTIC will debut his new hit single “PRAY FOR ME.” It's available on all digital streaming platforms. On Friday, August 1, 2025 the 5th Annual Pilgrim Festival will get underway

Building on the positive results of Phase 2 clinical trials in PSP and ALS, Transposon plans to initiate a Phase 2 clinical trial of TPN-101 for the treatment of Alzheimer's disease in Q4 2025 Concurrently, Transposon is advancing TPN-101 in the Phase 2/3 HEALEY ALS Platform trial Transposon Therapeutics, a biotechnology company focused on developing

Ceva, Inc. (NASDAQ: CEVA), the leading licensor of silicon and software IP that enables Smart Edge devices to connect, sense and infer data more reliably and efficiently, will announce results for the second quarter 2025 on August 11, 2025 before the NASDAQ market opens. Following the release, Ceva management will conduct a conference call at

Gestalt, a leading provider of AI-powered digital pathology solutions, showcased its AI-powered pathology platform, PathFlow, at the Spring 2025 DICOM WG-26 Interoperability Connectathon, confirming its readiness for real-world clinical integration and multi-vendor environments. The Connectathon was co-sponsored by the Digital Pathology Association (DPA) and the European Society of Digital and Integrative Pathology (ESDIP). The event,